Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Difene 100 mg Dual Release Capsules
Medicines register · Ireland

Difene 100 mg Dual Release Capsules

Authorisation PA2256/001/004 · Glenwood GmbH

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
Glenwood GmbH (all products →)
Active substance
Diclofenac sodium
Clinical trials
10 clinical trials →
Dosage form
Modified-release capsule, hard
Route of administration
Oral use
ATC codes
M01AB, M01AB05
First authorised
30/05/1997
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Generic application (Article 10(1) of Directive No 2001/83/EC)

Diclofenac sodium: supply and approvals

34 authorised products on the HPRA list contain Diclofenac sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
Diclofenac Sodium Tablet, Delayed Release: resolved, updated 13 Aug 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 29 years (since 30 May 1997). The HPRA list marks it as marketed in Ireland.

Other medicines with Diclofenac sodium in Ireland

31 other products on the HPRA list contain Diclofenac sodium, from 12 licence holders; 17 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Arthrotec 50 modified-release tabletsPfizer Healthcare Ireland Unlimited CompanyNational authorisation (PA)Marketed
Arthrotec 75 modified-release tabletsPfizer Healthcare Ireland Unlimited CompanyNational authorisation (PA)Marketed
Diclac 1% w/w GelRowex Limited,National authorisation (PA)Marketed
Diclac 100mg SuppositoriesRowex Limited,National authorisation (PA)Marketed
Diclac 50 mg Gastro-resistant TabletsRowex Limited,National authorisation (PA)Marketed
Diclac 75 mg Prolonged-release TabletRowex Limited,National authorisation (PA)Marketed
Diclac Relief 1% w/w GelRowex Limited,National authorisation (PA)Marketed
Diclac Retard 100 mg Prolonged-release TabletsRowex Limited,National authorisation (PA)Marketed
Difene 1% w/w GelGlenwood GmbHNational authorisation (PA)Marketed
Difene 25mg CapsulesGlenwood GmbHNational authorisation (PA)Marketed
Difene 50mg CapsulesGlenwood GmbHNational authorisation (PA)Marketed
Difene 75 mg Dual Release CapsulesGlenwood GmbHNational authorisation (PA)Marketed

All 32 products with Diclofenac sodium →

Other substances in ATC group M01AB

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 4 other active substances share the group M01AB with this product:

Misoprostol (5) · Diclofenac potassium (2) · Lactose monohydrate (1) · Aceclofenac (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Glenwood GmbH holds 14 products on the HPRA list, with 4 different active substances; 12 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.